Related Experiment Video
Updated: May 26, 2026

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone
11st Medical Department, Hanusch Hospital, Vienna, Austria. peter.mikosch@tele2.at
Insights
Gaucher disease (GD) causes bone problems like pain and fractures. Current treatments, including enzyme replacement and substrate reduction therapy, improve bone health and reduce symptoms in patients with this genetic disorder.
Area of Science:
- Genetics and Genetic Diseases
- Metabolic Diseases
- Hematology
Background:
- Gaucher disease (GD) is an inherited lysosomal storage disorder impacting multiple organs.
- Non-neuronopathic GD, the most common type, presents with various symptoms including hepatosplenomegaly, anemia, and skeletal issues.
- Bone manifestations in GD are significant, encompassing infarcts, avascular necrosis, osteosclerosis, fractures, and osteomyelitis, severely affecting patient morbidity.
Purpose of the Study:
- To provide a comprehensive overview of bone pathologies in Gaucher disease.
- To discuss the pathophysiology, diagnostics, and clinical management of GD bone manifestations.
- To evaluate the therapeutic effects of enzyme replacement therapy (ERT), substrate reduction therapy (SRT), and bone-specific treatments on GD bone disease.
Main Methods:
- Review of existing literature on Gaucher disease bone pathology.
- Analysis of clinical data regarding diagnostic approaches.
- Assessment of therapeutic outcomes from ERT, SRT, and other relevant treatments.
Main Results:
- Available therapies like ERT and SRT rapidly improve hematological and visceral symptoms in GD.
- These therapies also demonstrate beneficial effects on bone pain, bone crises, and osteoporosis progression.
- The article details the pathophysiology and diagnostic criteria for GD bone complications.
Conclusions:
- Gaucher disease significantly impacts bone health, leading to pain, fractures, and reduced quality of life.
- Enzyme replacement therapy and substrate reduction therapy offer significant benefits for bone manifestations in GD.
- Further focus on bone-specific therapies alongside current treatments is crucial for comprehensive GD management.
Abstract:
Gaucher disease (GD) is an inherited lysosomal storage disorder affecting multiple organs. Non-neuronopathic GD, the most common form, can present with hepatosplenomegaly, anaemia, bleeding tendencies, thrombocytopenia, skeletal pathologies, growth retardation and, in severe cases, with pulmonary disease. The bone manifestations include bone infarcts, avascular bone necrosis, lytic lesions, osteosclerosis, fractures due to osteoporosis and, rarely, acute osteomyelitis. Bone pain of varying intensity, fractures and joint collapses increase the patients' morbidity and impair their mobility and quality of life. Currently available therapies - enzyme replacement therapy and substrate reduction therapy - have shown to improve blood count and the visceral manifestations within a short time. Beneficial effects have also been documented on bone pain, bone crises and the extent of osteoporosis. The article focusses on the bone pathologies of GD including its pathophysiology, current diagnostics, clinical management and therapeutic effects of enzyme replacement therapy, substrate reduction therapy and bone-specific therapies.
Related Concept Videos
Disorders of the Skeletal Muscle
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Lysosomal Hydrolases
Proteoglycans
The Functions of the Skeletal System
Glycosaminoglycans
GAGS are found in the extracellular matrix of vertebrates, invertebrates, and bacteria. Due to their polar nature they attract water, and serve as excellent lubricants or shock absorbers in an animal body.
Hyaluronic...
